The 340B Program enables covered entities to stretch scarce federal resources as far as possible, reaching more eligible patients and providing more comprehensive services. Manufacturers participating in Medicaid agree to provide outpatient drugs to covered entities at significantly reduced prices.

2020年6月15日 · This review will provide an overview of DOAC s and act as a practical reference for clinicians to optimize DOAC use among common challenging scenarios. Topics addressed include (1) appropriate indications; (2) use in patients with specific comorbidities; (3) monitoring parameters; (4) transitioning between anticoagulant regimens; (5) major drug ...

Although acquiring drugs at lower costs can provide a financial benefit to 340B hospitals, the complexities of the ambulatory pharmacy environment require thoughtful planning and adaptability to ensure success. Here are six questions to help you effectively manage your ambulatory and specialty 340B program guidelines. 1.

The 340B Prime Vendor Program (PVP) is a contract awarded by HRSA, which is responsible for administering the 340B Drug Pricing Program. The Prime Vendor negotiates pricing discounts with participating manufacturers, provides education and resources such as 340B University, and offers technical assistance through Apexus Answers.

The 340B Program Handbook is designed as a practical guide for pharmacy leaders, hospital administrators, business managers, and pharmacy supply chain professionals implementing, main-taining, or overseeing a high-performing 340B program.

2021年10月12日 · What are the benefits of participating in the 340B Program? biggest benefit is the savings on drug costs, which allows 318 grantees and subgrantees to expand their formularies to include more costly therapeutic option.

The 340B Drug Pricing Program is a US federal government program created in 1992 that requires drug manufacturers to provide outpatient drugs to eligible health care organizations and covered entities at significantly reduced prices.

2023年6月1日 · 美国340B药品定价计划。 20 世纪 90 年代，美国对符合一定条件的医疗机构实体门诊药品实施了 340B 药品定价计划（ 340B drug pricing program ，后简称“ 340B 计划”），通过加入院外药房作为药品供应窗口来提高药品可及性，从而降低门诊药品价格，扩大医疗保障的 ...

Medicare makes changes to the reimbursement and coverage of prescription drugs on an annual basis. The Health Resources and Services Administration (HRSA) administers the 340B Drug …

Section 340B of the Public Health Service Act requires pharmaceutical manufacturers participating in Medicaid to sell outpatient drugs at discounted prices to health care organizations that care for many uninsured and low-income patients.